CRGX Insider Trading Activity and SEC Form 4 Filings
CRGX insider trading summary
No open-market insider purchases or sales of CARGO Therapeutics, Inc. (CRGX) have been reported on SEC Form 4 in the past 12 months.
Latest CRGX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 2, 2025 | Anup Radhakrishnan | See Remarks | Sell | $7K (1,632 @ $4.18) |
| May 14, 2025 | Anup Radhakrishnan | See Remarks | Sell | $105K (27,404 @ $3.84) |
| Apr 3, 2025 | Anup Radhakrishnan | See Remarks | Sell | $7K (1,629 @ $4.00) |
| Sep 19, 2024 | Gina Chapman | President & CEO | Sell | $74K (2,975 @ $25.03) |
| Sep 18, 2024 | Gina Chapman | President & CEO | Sell | $180K (7,166 @ $25.09) |
| Sep 18, 2024 | Anup Radhakrishnan | Chief Financial Officer | Sell | $40K (1,600 @ $25.28) |
| May 30, 2024 | Srinivas Akkaraju | 10% Owner | Buy | $5.0M (294,000 @ $17.00) |
| May 30, 2024 | Samsara BioCapital, L.P. | 10% Owner | Buy | $5.0M (294,000 @ $17.00) |
| May 30, 2024 | Samsara BioCapital GP, LLC | Insider | Buy | $5.0M (294,000 @ $17.00) |
| Nov 14, 2023 | Perceptive Advisors LLC | Insider | Buy | $5.0M (333,333 @ $15.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.